Psychedelic Drugmaker Definium Surges on Depression Drug Success

Bloomberg Jun 22, 2026 3h ago ⏱ 1 min read 👁 3 views

Image via Bloomberg

📋 Article Summary

44 words

Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders. This story was reported by Bloomberg. For more Finance news in Kenya, stay tuned to Masaa.

This is a summary. Read the complete story on Bloomberg below.

Full story on Bloomberg

Read Full Story →

🔗 Clicking will take you to www.bloomberg.com

👁 People Also Read

Finance

Sorry, Elon, the far right is still the far right

And on some issues, it’s further to the right than before

Read

Finance

A Stock Trader’s Guide to Navigating a Rare ‘Super El Niño’

As concerns over the Iran war recede, stock investors are confronting another threat: climate risk, which is prompting a reassessment…

Read

Finance

Oil Stockpiles Near Danger Zone

Energy markets expert and author of Oil's Endless Bid Dan Dicker says oil markets are underestimating the impact of ongoing…

Read

Finance

Inghams Shares Tumble as Farms Locked Down in Fight Against H5N1

Shares in Australia-listed chicken producer Inghams Group Ltd. dropped as much as 14% in early Monday trading after the company…

Read

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.